Concerns for the use of Basement Membrane Extract (BME)
Cutting-edge in vitro models like organoids and pluripotent stem cells are shaping the future of biomedical research. Yet many of these advancements still rely on animal-derived materials like Basement Membrane Extract (BME). Despite being a go-to choice for 2D and 3D cell cultures for over 40 years, the use of BME comes with major ethical, sustainability, practical, and scientific drawbacks that limits its reliability and translational potential.
On this page, we have summarized the key issues associated with BME and why transitioning to animal-free alternatives is crucial for more reliable, reproducible, and ethical research. If you're looking for BME-free alternatives, please check our BME-free Database to explore available options.
Production of Basement Membrane Extract (BME) is unethical and unsustainable

Did you know that every 10 mL bottle of BME requires the sacrifice of two mice? These mice are purpose-bred and injected with Engelbreth-Holm-Swarm (EHS) tumours, causing them to experience suffering. This process is not only inhumane, but also unsustainable, requiring a lot of resources for breeding, housing, and maintaining facilities for these animals.
How many of these bottles did you come across in your research?
Xenogeneic origin limits clinical translation

When using Basement Membrane Extract (BME) we are exposing cultured cells to a murine-derived microenvironment. Unless you are working with murine cells, this may compromise the experimental results due to biological incompatibility and variability and also hinders regulatory approval from the EMA or FDA for human applications.
What is holding you back from developing models with animal-free materials for better clinical translation?